Literature DB >> 8204629

Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activity.

D D Pittman1, K N Tomkinson, D Michnick, U Selighsohn, R J Kaufman.   

Abstract

Factor VIII and factor V function as cofactors in the blood coagulation cascade to accelerate the rate of activation of factor X and prothrombin, respectively. Both cofactors require proteolytic activation by either activated factor X or thrombin for functional activity. Human factor VIII and factor V expressed in mammalian cells are both modified by posttranslational sulfation of tyrosine residues. In the present study, the posttranslational addition of sulfate in factor V expressed in transfected Chinese hamster ovary (CHO) cells was demonstrated by [35S]sulfate incorporation into the thrombin-cleaved 94-kDa heavy chain and the 150-kDa activation peptide. The presence of tyrosine sulfate in recombinant factor V was confirmed by barium hydroxide hydrolysis and two-dimensional thin-layer electrophoresis. The importance of sulfation for factor V secretion and activity was evaluated by characterizing factor V expressed in Chinese hamster ovary cells grown in the presence of sodium chlorate, a potent inhibitor of posttranslational sulfation in intact cells. Increasing concentrations of sodium chlorate inhibited the incorporation of [35S]sulfate into factor V but did not inhibit the synthesis or secretion of factor V. However, the specific activity of factor V secreted in the presence of sodium chlorate was reduced 5-fold. The reduced activity was attributed to (1) slower cleavage and activation by thrombin and (2) a reduced intrinsic activity of factor Va. In contrast, sulfation of factor V did not affect the rate of activation mediated by factor Xa. These results show that sulfation of factor V is required for efficient thrombin activation but not for activation by factor Xa.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8204629     DOI: 10.1021/bi00188a026

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Processing of proaugurin is required to suppress proliferation of tumor cell lines.

Authors:  Akihiko Ozawa; Adam N Lick; Iris Lindberg
Journal:  Mol Endocrinol       Date:  2011-03-24

Review 2.  The structural role of receptor tyrosine sulfation in chemokine recognition.

Authors:  Justin P Ludeman; Martin J Stone
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Detection and purification of tyrosine-sulfated proteins using a novel anti-sulfotyrosine monoclonal antibody.

Authors:  Adam J Hoffhines; Eugen Damoc; Kristie G Bridges; Julie A Leary; Kevin L Moore
Journal:  J Biol Chem       Date:  2006-10-17       Impact factor: 5.157

4.  Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction.

Authors:  María Ángeles Corral-Rodríguez; Paul E Bock; Erick Hernández-Carvajal; Ricardo Gutiérrez-Gallego; Pablo Fuentes-Prior
Journal:  Blood       Date:  2011-05-09       Impact factor: 22.113

5.  Lack of tyrosylprotein sulfotransferase-2 activity results in altered sperm-egg interactions and loss of ADAM3 and ADAM6 in epididymal sperm.

Authors:  Matthew R Marcello; Weitao Jia; Julie A Leary; Kevin L Moore; Janice P Evans
Journal:  J Biol Chem       Date:  2011-02-21       Impact factor: 5.157

6.  The role of thrombin exosites I and II in the activation of human coagulation factor V.

Authors:  Kenneth Segers; Björn Dahlbäck; Paul E Bock; Guido Tans; Jan Rosing; Gerry A F Nicolaes
Journal:  J Biol Chem       Date:  2007-09-18       Impact factor: 5.157

7.  Contribution of amino acid region 659-663 of Factor Va heavy chain to the activity of factor Xa within prothrombinase .

Authors:  Jamila Hirbawi; John L Vaughn; Michael A Bukys; Hans L Vos; Michael Kalafatis
Journal:  Biochemistry       Date:  2010-09-13       Impact factor: 3.162

Review 8.  The molecular basis of factor V and VIII procofactor activation.

Authors:  R M Camire; M H A Bos
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

9.  Lack of tyrosylprotein sulfotransferase activity in hematopoietic cells drastically attenuates atherosclerosis in Ldlr-/- mice.

Authors:  Andrew D Westmuckett; Kevin L Moore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-13       Impact factor: 8.311

10.  Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.

Authors:  Lisa M Vincent; Sinh Tran; Ruzica Livaja; Tracy A Bensend; Dianna M Milewicz; Björn Dahlbäck
Journal:  J Clin Invest       Date:  2013-08-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.